Header Logo

Connection

Jamie Miller to Substance Withdrawal Syndrome

This is a "connection" page, showing publications Jamie Miller has written about Substance Withdrawal Syndrome.
Connection Strength

0.647
  1. Selection of the initial methadone regimen for the management of iatrogenic opioid abstinence syndrome in critically ill children. Pharmacotherapy. 2012 Feb; 32(2):148-57.
    View in: PubMed
    Score: 0.381
  2. Clonidine for Sedation and Analgesia and Withdrawal in Critically Ill Infants and Children. Pharmacotherapy. 2016 12; 36(12):1290-1299.
    View in: PubMed
    Score: 0.133
  3. Alpha2-receptor agonists for treatment and prevention of iatrogenic opioid abstinence syndrome in critically ill patients. Ann Pharmacother. 2009 Sep; 43(9):1506-11.
    View in: PubMed
    Score: 0.081
  4. Ketamine Continuous Infusions in Critically Ill Infants and Children. Ann Pharmacother. 2016 Mar; 50(3):234-41.
    View in: PubMed
    Score: 0.031
  5. Lofexidine, an {alpha}2-receptor agonist for opioid detoxification. Ann Pharmacother. 2010 Feb; 44(2):343-51.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.